TIANFUCHEM--217500-96-4--Tulathromycin A CAS NO.217500-96-4

product name:tulathromycin asynonyms:tulathromycin a;(2r,3s,4r,5r,8r,10r,11r,12s,13s,14r)-13-[[2,6-dideoxy-3-c-methyl-3-o-methyl-4-c-[(propylamino)methyl]-a-l-ribo-hexopyranosyl]oxy]-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-b-d-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one;unii-897a3kn7ap;(2r,3s,4r,5r,8r,10r,11r,12s,13s,14r)-13-[[2,6-dideoxy-3-c-methyl-3-o-methyl-4-c-[(propylamino)methyl]-α-l-ribo-hexopyranosyl]oxy]-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-β-d-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one;cp 472295;draxxin;tulathromycin a, >=95%;tulathrmycin acas:217500-96-4mf:c41h79n3o12mw:806.084einecs:product categories:carbohydrates & derivatives;chiral reagents;intermediates & fine chemicals;pharmaceuticals;apimol file:217500-96-4.mol
tulathromycin a chemical properties
density 1.17
safety information
msds information
tulathromycin a usage and synthesis
chemical propertieswhite solidusestulathromycin is a semi-synthetic erythromycin belonging to the ring expanded aza–erythromycins. ring expansion improvedsthe acid lability of the parent erythromycins. tulathromycin is regarded as the first of the triamilides, having a third amino (propylaminomethylene) group on a sugar to improve absorption. this modification provides a mixture of the two tulathromycin isomers (90:10) present in the commercial animal health product.usestulathromycin is a semi-synthetic erythromycin belonging to the ring expanded aza–erythromycins. ring expansion improves the acid lability compared with the parent erythromycins. tulathromycin is regarded as the first of the triamilides, having a third amino (propylaminomethylene) group on a sugar to improve absorption. this modification provides a mixture of the two tulathromycin isomers (90:10) present in the commercial animal health product.usestriamilide antibiotic for treatment of bovine and porcine respiratory disease. exists as an equilibrium mixture of two isomeric forms, tulathromycin a (90%) and b (10%). antibacterial.